The Significance of Continuous Dopaminergic Stimulation in the Treatment of Parkinson??s Disease
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 55 (Supplement) , 1-9
- https://doi.org/10.2165/00003495-199855001-00001
Abstract
Levodopa continues to be the most effective agent for the symptomatic treatment of Parkinson’s disease. No other drug matches its ability to suppress parkinsonian symptoms, especially in patients...Keywords
This publication has 44 references indexed in Scilit:
- Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexoleJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1997
- Adjunctive Cabergoline Therapy of Parkinson's Disease: Comparison with Placebo and Assessment of Dose Responses and Duration of EffectClinical Neuropharmacology, 1996
- Cyclic adenosine‐3′,5′‐monophosphate potentiates the synaptic potential mediated by NMDA receptors in the amygdalaJournal of Neuroscience Research, 1995
- Parkinson's Disease: From Etiology to Treatment.Internal Medicine, 1995
- NMDA receptor blockade reverses motor response alterations induced by levodopaNeuroReport, 1994
- N‐0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's diseaseMovement Disorders, 1994
- Continuous lisuride effects on central dopaminergic mechanisms in Parkinson's diseaseAnnals of Neurology, 1992
- D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal NeuronsScience, 1990
- Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part IAnnals of Neurology, 1988
- Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part IIAnnals of Neurology, 1988